| Product Definition | The specification should clearly state whether the material is native or undenatured collagen, hydrolyzed collagen, gelatin, or another collagen-derived ingredient. These categories should not be used interchangeably. | Technical data sheet, product specification, manufacturing flow chart, and intended-use statement. | Consistent terminology, defined product identity, and a documented explanation of how the processing method supports the claimed collagen form. | Marketing language that describes hydrolyzed collagen as undenatured collagen without supporting technical evidence. |
| Native Structure Preservation | For an undenatured collagen claim, the supplier should define the structural attribute being protected, such as the native triple-helix structure or a specified functional conformation. | Validated analytical method, test report, process-control records, and representative batch results. | The test method, acceptance criteria, sampling plan, and results are traceable to the supplied batch. | Only a generic protein assay is provided as proof of native collagen structure. |
| Raw-Material Traceability | The origin, species, tissue source, supplier lot, receiving date, and processing batch should be traceable from finished product back to the raw material. | Traceability procedure, lot-number example, approved-supplier list, incoming inspection records, and mock-recall report. | The supplier can complete a documented one-step-back and one-step-forward traceability exercise within its stated response time. | Unclear animal source, missing lot linkage, or inability to identify the origin of a finished batch. |
| Food-Safety Management | A documented HACCP-based food-safety system should identify biological, chemical, and physical hazards and define preventive controls. | HACCP plan, hazard analysis, monitoring records, corrective-action records, and current food-safety audit report. | Hazards are linked to specific control measures, limits, monitoring frequency, verification, and corrective actions. | A certificate is displayed without a usable hazard analysis or evidence of implementation. |
| Management-System Certification | Certification such as ISO 22000, FSSC 22000, BRCGS, or an equivalent recognized food-safety scheme should match the manufacturing site and product scope. | Certificate number, scope, site address, validity period, certification body, and latest audit status. | The certificate is current, independently verifiable, and covers the actual collagen production activity. | The certificate belongs to another site, excludes the relevant process, or has expired. |
| GMP and Hygienic Production | The facility should control personnel hygiene, sanitation, pest management, equipment maintenance, water quality, allergen handling, and environmental conditions. | GMP procedures, sanitation logs, pest-control reports, environmental-monitoring results, and facility audit records. | Controlled hygiene procedures are supported by completed records and documented corrective actions. | Cleanliness is shown only during a visit, with no routine records or verification history. |
| Identity and Purity | The product specification should define appearance, odor, moisture, protein content, ash, pH or solution characteristics, and any product-specific identity tests. | Specification sheet, certificate of analysis, validated methods, reference standards, and independent laboratory results. | Acceptance limits are numerical, test methods are identified, and results are reported for each production lot. | Only a single protein percentage is reported, with no identity or purity profile. |
| Microbiological Safety | Testing should address relevant total counts and specified pathogens according to the destination market, product category, and customer specification. | Lot-specific microbiological certificate of analysis, laboratory accreditation details, test methods, and sampling plan. | Results are linked to the lot number and tested by a competent internal or independent laboratory. | Undated reports, pooled samples, absent pathogen criteria, or results unrelated to the supplied lot. |
| Chemical Contaminants | The risk assessment should cover heavy metals, residues, prohibited substances, cleaning-chemical carryover, and other contaminants relevant to the raw material and destination market. | Contaminant test reports, risk assessment, raw-material declarations, and destination-market compliance statement. | Testing frequency and limits are risk-based and clearly mapped to applicable regulations or customer requirements. | A general “chemical-free” claim without analyte lists, limits, or test evidence. |
| Allergen and Species Controls | The supplier should disclose species, source tissue, shared-line risks, allergen status, and cross-contact controls where applicable. | Allergen statement, species declaration, shared-equipment assessment, cleaning validation, and segregation procedure. | Declarations are consistent across labels, specifications, certificates, and shipping documents. | Species or allergen information changes between documents or is withheld as “confidential.” |
| Country-of-Origin and Religious Compliance | Where required by the market, the supplier should provide documentation for halal, kosher, vegetarian restrictions, or other origin-related requirements. | Valid certificate, product scope, issuing body, raw-material declaration, and segregation or chain-of-custody records. | The certificate covers the exact product and manufacturing site, not merely the supplier’s general operations. | A general facility certificate is used to support a claim for a specific product without scope confirmation. |
| Batch Consistency | Critical quality attributes should remain within agreed specifications across at least several consecutive commercial or pilot batches. | Three or more representative batch certificates, trend charts, deviation records, and retain-sample policy. | Results show stable quality, controlled deviations, and a defined release process before shipment. | Only one favorable sample is supplied or specifications are changed after ordering. |
| Laboratory Competence | Critical tests should be performed using suitable, validated, or recognized methods by a competent laboratory. | Laboratory accreditation scope, method references, proficiency-testing evidence, calibration records, and analyst qualification records. | The laboratory’s scope covers the reported tests and instruments are calibrated at defined intervals. | Reports omit methods, units, detection limits, laboratory details, or sample identification. |
| Regulatory and Label Support | The supplier should support the buyer’s intended food, supplement, cosmetic, or technical application without making unauthorized disease or treatment claims. | Regulatory questionnaire, ingredient statement, safety data where applicable, export documents, and destination-market compliance review. | Claims are supported by evidence and adapted to the legal requirements of the importing country. | The supplier guarantees approval in every country or promotes medical claims for a food ingredient. |
| Packaging and Shelf Life | Packaging should protect the powder from moisture, contamination, light, and physical damage under the specified storage conditions. | Packaging specification, food-contact declaration where applicable, stability data, storage instructions, and shelf-life justification. | Shelf life is supported by real-time or scientifically justified stability data and clear lot/date coding. | Long shelf life is quoted without storage conditions, stability evidence, or packaging specifications. |
| Production Capacity and Lead Time | Capacity claims should distinguish installed capacity, normal monthly output, available capacity, minimum order quantity, and confirmed lead time. | Capacity statement, production schedule, order history summary, inventory policy, and written delivery terms. | The supplier provides realistic planning data and communicates delays or allocation limits promptly. | Very large capacity claims conflict with facility size, audit scope, or actual delivery performance. |
| Quality Agreement and Change Control | A written quality agreement should define specifications, testing, deviations, complaints, recalls, audits, confidentiality, and advance notice of material changes. | Signed quality agreement, change-control procedure, complaint log template, recall procedure, and audit-rights clause. | Changes to raw materials, process, site, specification, or packaging require documented evaluation and buyer notification. | The supplier can change raw materials or production sites without prior notification. |
| Sample-to-Commercial Match | The approved sample, pilot batch, and commercial batch should meet the same agreed specification and functional requirements. | Sample approval record, retained sample, pilot-batch results, commercial-batch certificate, and pre-shipment inspection report. | The supplier accepts comparison testing and provides a documented process for handling out-of-specification results. | The commercial material differs in color, solubility, odor, assay, structure, or packaging without an approved deviation. |
.svg)
